Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli
Authors:
Open Access
- 1 June 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Pharmaceutical Fronts
- Vol. 03 (02) , e39-e49
Abstract
With the advancement of genetic engineering, monoclonal antibodies (mAbs) have made far-reaching progress in the treatment of various human diseases. However, due to the high cost of production, the increasing demands for antibody-based therapies have not been fully met. Currently, mAb-derived alternatives, such as antigen-binding fragments (Fab), single-chain variable fragments, bispecifics, nanobodies, and conjugated mAbs have emerged as promising new therapeutic modalities. They can be readily prepared in bacterial systems with well-established fermentation technology and ease of manipulation, leading to the reduction of overall cost. This review aims to shed light on the strategies to improve the expression, purification, and yield of Fab fragments in Escherichia coli expression systems, as well as current advances in the applications of Fab fragments. # These authors contributed equally to this work. Received: 27 May 2021 Accepted: 03 July 2021 Article published online: 02 September 2021 © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
Funding Information
- National Natural Science Foundation of China (2070722)
- National Science and Technology Major Project (2019ZX09201001-003-008)
- Shanghai Jiao Tong University Medicine Engineering Joint Funding (YG2019ZDA04)
- Shanghai Jiao Tong University Medicine Engineering Joint Funding (YG2019QNA50)
This publication has 86 references indexed in Scilit:
- Effect of culture medium, host strain and oxygen transfer on recombinant Fab antibody fragment yield and leakage to medium in shaken E. coli culturesMicrobial Cell Factories, 2013
- Strategies for production of active eukaryotic proteins in bacterial expression systemAsian Pacific Journal of Tropical Biomedicine, 2012
- A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyCell Death & Differentiation, 2012
- Certolizumab PegolmAbs, 2010
- Co-expression of Skp and FkpA chaperones improves cell viability and alters the global expression of stress response genes during scFvD1.3 productionMicrobial Cell Factories, 2010
- Experimental confirmation of a key role for non-optimal codons in protein exportBiochemical and Biophysical Research Communications, 2007
- Solubilization and refolding of bacterial inclusion body proteinsJournal of Bioscience and Bioengineering, 2005
- Isolation of proteins that speifically interact with the ATPase domain of mammalian ER chaperone, BiPBiotechnology and Bioprocess Engineering, 2003
- High level production of functional antibody fab fragments in an oxidizing bacterial cytoplasm11Edited by J. KarnJournal of Molecular Biology, 2002
- Interaction of the Periplasmic Peptidylprolylcis-trans Isomerase SurA with Model PeptidesJournal of Biological Chemistry, 2001